UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000009996
Receipt number R000011704
Scientific Title MRI Measurement of Lead Location for Suboptimal Outcomes after Deep Brain Stimulation
Date of disclosure of the study information 2013/02/27
Last modified on 2022/12/09 10:19:24

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

MRI Measurement of Lead Location for
Suboptimal Outcomes after Deep Brain Stimulation

Acronym

MRI trouble shooting for DBS study (MRI-DBS study)

Scientific Title

MRI Measurement of Lead Location for
Suboptimal Outcomes after Deep Brain Stimulation

Scientific Title:Acronym

MRI trouble shooting for DBS study (MRI-DBS study)

Region

Japan


Condition

Condition

Parkinson's disease, dystonia, tremor

Classification by specialty

Neurology Neurosurgery

Classification by malignancy

Others

Genomic information

NO


Objectives

Narrative objectives1

To assess the efficacy and safety of measuring lead location by brain MRI for patients with suboptimal clinical efficacy of deep brain stimulation (DBS) and to assess efficacy of repositioning or adding DBS lead(s).

Basic objectives2

Safety,Efficacy

Basic objectives -Others


Trial characteristics_1


Trial characteristics_2

Pragmatic

Developmental phase

Phase II


Assessment

Primary outcomes

The Parkinson's Disease Questionnaire (PDQ-39)

Key secondary outcomes

1.Unified Parkinoson's Disease Rating Scale (UPDRS) part I, II, IV
2.UPDRS-III (on/off stimulation, on/off medication)
3. Impedance
4.threshoulds for efficacy and side effect of DBS
5. Beck Depression Inventory (BDI)
6. Hamilton Rating Scale for Depression (HAMD)
7. Montgomery-Asberg Depression Scale (MADRS)
8. Zung Self-rating Depression Scale (SDS)
9. Apathy scale (AS)
10. Mini-Mental State Examination (MMSE)
11. Frontal Assessment Battery (FAB)
12.Japanese version of Montreal Cognitive Assessment (MoCA-J)
13.Keio version Wisconsin card sorting test (KWCST)
14. other complications


Base

Study type

Interventional


Study design

Basic design

Single arm

Randomization

Non-randomized

Randomization unit


Blinding

Open -no one is blinded

Control

Uncontrolled

Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms

1

Purpose of intervention

Treatment

Type of intervention

Device,equipment Maneuver

Interventions/Control_1

MRI

Interventions/Control_2


Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

20 years-old <=

Age-upper limit

99 years-old >

Gender

Male and Female

Key inclusion criteria

Include either 1 or 2:
1. Patients with suboptimal clinical efficacy after DBS therapy.
2. Patients who cannot increase DBS settings due to stimulation induced side effects.

Key exclusion criteria

Exclusion criteria are following.
1. Pregnant women and, nursing mothers
2. Patients who have cardiac pacemaker.
3. Patients who cannot understand the concept of this study or who cannot obtain written consent.
4. Patients who are assumed not to be appropriate candidate for this study by investigators.

Target sample size

20


Research contact person

Name of lead principal investigator

1st name
Middle name
Last name Yasushi Shimo

Organization

Juntendo University

Division name

Department of Research and Therapeutics for Movement Disorders

Zip code


Address

2-1-1 Hongo, Bunkyo-ku, Tokyo 113-0033

TEL

+81-3-3813-3111-

Email

yshimo@juntendo.ac.jp


Public contact

Name of contact person

1st name
Middle name
Last name Genko Oyama

Organization

Juntendo University

Division name

Department of Neurology

Zip code


Address

2-1-1 Hongo, Bunkyo, Tokyo

TEL

+81-3-3813-3111

Homepage URL


Email

g_oyama@jutendo.ac.jp


Sponsor or person

Institute

Juntendo University

Institute

Department

Personal name



Funding Source

Organization

None

Organization

Division

Category of Funding Organization

Self funding

Nationality of Funding Organization

Japan


Other related organizations

Co-sponsor

None

Name of secondary funder(s)

None


IRB Contact (For public release)

Organization


Address


Tel


Email



Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions

順天堂大学附属順天堂医院(東京)


Other administrative information

Date of disclosure of the study information

2013 Year 02 Month 27 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Terminated

Date of protocol fixation

2013 Year 02 Month 04 Day

Date of IRB

2013 Year 02 Month 01 Day

Anticipated trial start date

2013 Year 02 Month 04 Day

Last follow-up date

2022 Year 12 Month 31 Day

Date of closure to data entry

2022 Year 12 Month 31 Day

Date trial data considered complete

2022 Year 12 Month 31 Day

Date analysis concluded

2022 Year 12 Month 31 Day


Other

Other related information



Management information

Registered date

2013 Year 02 Month 07 Day

Last modified on

2022 Year 12 Month 09 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000011704


Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name